Video1
Video2 Video3 Video4 Video5 Video
6Video 7Video 8Video
9Video 10*The scientific details regarding
this treatment, perfomed at the INR in 2001, have been
peer-reviewed and were published in 2003. see Tobinick, E., Targeted
etanercept for discogenic neck pain. Clinical Therapeutics
2003 Apr;25(4):1211-8. See also Tobinick, E., Perispinal etanercept
for neuroinflammatory disorders Drug Discovery Today
2009 Feb;14(3-4):168-77; Tobinick, E. and S. Davoodifar, Efficacy
of etanercept delivered by perispinal administration for chronic
back and/or neck disc-related pain: a study of clinical observations
in 143 patients. Curr Med Res Opin, 2004. 20(7): p. 1075-85;
Tobinick, E.L. and S. Britschgi-Davoodifar, Perispinal TNF-alpha
inhibition for discogenic pain. Swiss Med Wkly, 2003. 133(11-12):
p. 170-7. Disclaimer: Individual
results vary. Anti-TNF treatment for the indications above is
off-label. Please see the Legal
Disclaimer. Some patients do not respond. More than one dose
may be necessary for optimal effect. The video above shows an
actual patient of the INR who was treated for severe disc-related
pain in 2001 at the INR.
Return to Home Page